Identification of Fibroblast Activation Protein as an Osteogenic Suppressor and Anti-osteoporosis Drug Target
Open Access
- 1 October 2020
- journal article
- research article
- Published by Elsevier BV in Cell Reports
- Vol. 33 (2), 108252
- https://doi.org/10.1016/j.celrep.2020.108252
Abstract
No abstract availableKeywords
Funding Information
- National Key Program on Stem Cell and Translational Research (2017YFA0106400)
- National Natural Science Foundation of China (91749124, 81772389)
- Fundamental Research Funds for the Central Universities (22120190149, kx0200020173386)
This publication has 58 references indexed in Scilit:
- Bone histomorphometry using free and commonly available softwareHistopathology, 2012
- Isolation of the stromal-vascular fraction of mouse bone marrow markedly enhances the yield of clonogenic stromal progenitorsBlood, 2012
- Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γProceedings of the National Academy of Sciences of the United States of America, 2012
- Endothelial and perivascular cells maintain haematopoietic stem cellsNature, 2012
- Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–αScience, 2010
- Normal table of postembryonic zebrafish development: Staging by externally visible anatomy of the living fishDevelopmental Dynamics, 2009
- Nuclear Dvl, c-Jun, β-catenin, and TCF form a complex leading to stabiLization of β-catenin–TCF interactionThe Journal of cell biology, 2008
- Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation proteinBlood, 2006
- Zebrafish Prickle, a Modulator of Noncanonical Wnt/Fz Signaling, Regulates Gastrulation MovementsCurrent Biology, 2003
- Stages of embryonic development of the zebrafishDevelopmental Dynamics, 1995